Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Dec-09 9:44 AM View:  | Warburg Pincus Private Equi... | Neurogen Corp. (NRGN) | 23-Dec-09 | Disposition (other) | 13,571,400 | -- | -- | (100%) 13.57M to 0 | |
| 24-Dec-09 9:49 AM View: | Hen Stewart | Neurogen Corp. (NRGN) | 23-Dec-09 | Disposition (other) Duplicate | 13,571,400 | -- | -- | (100%) 13.57M to 0 | |
| 28-Jul-08 4:31 PM View: | Hen Stewart Director | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion Duplicate | 4,999,980 | -- | -- | 58% 8.57M to 13.57M | |
| 13-Nov-08 4:38 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 1,304,550 | -- | -- | 59% 2.2M to 3.5M | |
| 13-Nov-08 4:30 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 125,112 | -- | -- | 59% 210.56K to 335.67K | |
| 29-Jul-08 5:03 PM View: | Simon John Director | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 249,990 | -- | -- | 427% 58.5K to 308.49K | |
| 13-Nov-08 4:36 PM View: | Baker Biotech Capital III (... Director 10% Owner | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 1,371,160 | -- | -- | 59% 2.31M to 3.68M | |
| 28-Jul-08 4:31 PM View: | Leff Jonathan S Director | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion Duplicate | 4,999,980 | -- | -- | 58% 8.57M to 13.57M | |
| 13-Nov-08 4:28 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 257,504 | -- | -- | 59% 433.35K to 690.86K | |
| 28-Jul-08 4:30 PM View: | Warburg Pincus Private Equi... Director 10% Owner | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 4,999,980 | -- | -- | 58% 8.57M to 13.57M | |
| 13-Jun-07 4:00 PM View: | Chenard Bertrand L SR VP, Chemistry | Neurogen Corp. (NRGN) | 11-Jun-07 | Market Sale | 3,851 | $7.92 | $30,499.90 | (40%) 9.63K to 5.78K | 97% |
| 30-Apr-07 12:02 PM View: | Hutchison Alan EVP, Discovery Research | Neurogen Corp. (NRGN) | 27-Apr-07 | Market Sale (Planned) | 7,200 | $6.92 | $49,793.60 | (100%) 7.2K to 0 | 96% |
| 27-Apr-07 10:46 AM View: | Hutchison Alan EVP, Discovery Research | Neurogen Corp. (NRGN) | 26-Apr-07 | Market Sale (Planned) | 3,200 | $6.93 | $22,172.90 | (31%) 10.4K to 7.2K | 96% |
| 27-Apr-07 10:43 AM View: | Hutchison Alan EVP, Discovery Research | Neurogen Corp. (NRGN) | 25-Apr-07 | Market Sale (Planned) | 6,100 | $7.01 | $42,749.40 | (37%) 16.5K to 10.4K | 96% |
| 25-Apr-07 12:58 PM View: | Hutchison Alan EVP, Discovery Research | Neurogen Corp. (NRGN) | 24-Apr-07 | Market Sale (Planned) | 5,000 | $6.94 | $34,684.00 | (13%) 39.9K to 34.9K | 96% |
| 24-Apr-07 4:32 PM View: | Hutchison Alan EVP, Discovery Research | Neurogen Corp. (NRGN) | 23-Apr-07 | Market Sale (Planned) | 2,500 | $6.95 | $17,382.90 | (7%) 35.62K to 33.12K | 96% |
| 25-Apr-07 12:57 PM View: | Hutchison Alan EVP, Discovery Research | Neurogen Corp. (NRGN) | 23-Apr-07 | Market Sale (Planned) | 1,000 | $6.98 | $6,980.00 | (4%) 22.5K to 21.5K | 96% |
| 02-Feb-07 4:31 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 31-Jan-07 | Disposition (other) | 17,987 | -- | -- | (4%) 451.34K to 433.35K | |
| 04-Oct-06 6:08 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 02-Oct-06 | Disposition (other) | 160,934 | -- | -- | (43%) 371.49K to 210.56K | |
| 24-May-06 2:09 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 22-May-06 | Market Sale (Planned) | 20,000 | $5.43 | $108,600.00 | (37%) 54.35K to 34.35K | 95% |
| 28-Apr-06 3:15 PM View: | Baker Biotech Capital III (... Director 10% Owner | Neurogen Corp. (NRGN) | 25-Apr-06 | Acquisition (other) | 2,307,660 | -- | -- | 100% 2.31M to 4.62M | |
| 28-Apr-06 3:15 PM View: | Baker Biotech Capital III (... Director 10% Owner | Neurogen Corp. (NRGN) | 25-Apr-06 | Disposition (other) | 2,307,660 | -- | -- | (50%) 4.62M to 2.31M | |
| 26-Apr-06 3:07 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 24-Apr-06 | Grant | 2,011 | $6.52 | $13,111.70 | 3% 77.34K to 79.35K | (96%) |
| 26-Apr-06 3:07 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 24-Apr-06 | Market Sale (Planned) | 25,000 | $6.34 | $158,400.00 | (32%) 79.35K to 54.35K | 96% |
| 26-May-05 10:00 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 25-May-05 | Market Sale (Planned) | 7,500 | $6.53 | $48,975.00 | (10%) 77.5K to 70.0K | 96% |
| 25-May-05 4:10 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 24-May-05 | Market Sale (Planned) | 7,500 | $6.75 | $50,625.00 | (8%) 92.34K to 84.84K | 96% |
| 25-May-05 4:10 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 23-May-05 | Grant | 1,539 | $6.86 | $10,557.50 | 1% 105.8K to 107.34K | (96%) |
| 25-May-05 4:10 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 23-May-05 | Exercise (out-of-the-money) | 15,000 | $7.01 | $105,150.00 | (14%) 107.34K to 92.34K | 96% |
| 29-Dec-04 10:26 AM View: | Butler Robert N Director | Neurogen Corp. (NRGN) | 28-Dec-04 | Market Option Sale | 2,776 | $9.15 | $25,400.40 | (58%) 4.78K to 2.0K | 97% |
| 29-Dec-04 10:26 AM View: | Butler Robert N Director | Neurogen Corp. (NRGN) | 28-Dec-04 | Option Exercise | 2,776 | $6.50 | $18,044.00 | 139% 2.0K to 4.78K | |
| 23-Dec-04 5:17 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 22-Dec-04 | Grant | 1,427 | $9.15 | $13,057.00 | 1% 104.38K to 105.8K | (97%) |
| 23-Dec-04 4:42 PM View: | Simon John Director | Neurogen Corp. (NRGN) | 22-Dec-04 | Option Exercise | 5,000 | $6.50 | $32,500.00 | (8%) 63.5K to 58.5K | |
| 23-Dec-04 5:20 PM View: | Davis Stephen Sr VP, Chief Business Officer Director | Neurogen Corp. (NRGN) | 22-Dec-04 | Grant | 487 | $9.15 | $4,456.05 | < 1% 56.24K to 56.73K | (97%) |
| 23-Dec-04 5:17 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 21-Dec-04 | Option Exercise | 34,982 | $6.50 | $227,383.00 | 34% 104.38K to 139.36K | |
| 23-Dec-04 5:11 PM View: | Novitch Mark M D Director | Neurogen Corp. (NRGN) | 21-Dec-04 | Option Exercise | 5,000 | $6.50 | $32,500.00 | 15% 34.0K to 39.0K | |
| 23-Dec-04 5:20 PM View: | Davis Stephen Sr VP, Chief Business Officer Director | Neurogen Corp. (NRGN) | 21-Dec-04 | Market Option Sale | 17,500 | $9.00 | $157,507.00 | (24%) 73.74K to 56.24K | 97% |
| 23-Dec-04 5:07 PM View: | Saxton Craig Director | Neurogen Corp. (NRGN) | 21-Dec-04 | Grant | 25,000 | $9.05 | $226,250.00 | 100% 0 to 25.0K | (97%) |
| 23-Dec-04 5:11 PM View: | Novitch Mark M D Director | Neurogen Corp. (NRGN) | 21-Dec-04 | Payment of Exercise | 3,591 | $9.05 | $32,498.60 | (9%) 39.0K to 35.41K | 97% |
| 23-Dec-04 5:17 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 21-Dec-04 | Market Option Sale | 34,982 | $9.05 | $316,475.00 | (25%) 139.36K to 104.38K | 97% |
| 23-Dec-04 5:20 PM View: | Davis Stephen Sr VP, Chief Business Officer Director | Neurogen Corp. (NRGN) | 21-Dec-04 | Option Exercise | 17,500 | $3.87 | $67,725.00 | 31% 56.24K to 73.74K | |
| 16-Dec-04 2:43 PM View: | Carlucci Frank C Director | Neurogen Corp. (NRGN) | 15-Dec-04 | Option Exercise | 5,000 | $9.14 | $45,700.00 | 4% 126.33K to 131.32K | (97%) |
| 02-Nov-04 9:22 PM View: | Baker Biotech Capital II Gp... Director 10% Owner | Neurogen Corp. (NRGN) | 13-Oct-04 | Disposition (other) | 268,465 | -- | -- | (12%) 2.31M to 2.04M | |
| 25-May-04 4:41 PM View: | Hutchison Alan Exec VP Discovery Research | Neurogen Corp. (NRGN) | 21-May-04 | Grant | 50,000 | -- | -- | 90% 55.52K to 105.52K | |
| 21-Apr-04 10:00 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase | 203,935 | $7.00 | $1,427,540.00 | 122% 167.56K to 371.49K | |
| 21-Apr-04 10:00 PM View: | Tisch James S 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase Duplicate | 267,858 | $7.00 | $1,875,010.00 | 39% 679.25K to 947.11K | |
| 21-Apr-04 10:00 PM View: | Tisch Thomas J 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase Duplicate | 267,858 | $7.00 | $1,875,010.00 | 27% 979.25K to 1.25M | |
| 21-Apr-04 10:00 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase | 1,915,920 | $7.00 | $13,411,500.00 | 685% 279.59K to 2.2M | |
| 21-Apr-04 10:00 PM View: | Tisch Andrew H 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase | 267,858 | $7.00 | $1,875,010.00 | 39% 679.25K to 947.11K | |
| 21-Apr-04 10:00 PM View: | Tisch Daniel R 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase Duplicate | 267,858 | $7.00 | $1,875,010.00 | 39% 679.25K to 947.11K | |
| 21-Apr-04 10:00 PM View: | Baker Biotech Capital II Gp... 10% Owner | Neurogen Corp. (NRGN) | 19-Apr-04 | Private Purchase | 2,241,290 | $7.00 | $15,689,000.00 | 3377% 66.37K to 2.31M |
